About FDA
Number of foreign inspections completed in the month resulting in an initial classification of Voluntary Action Indicated (VAI)
Measure was implemented starting January 1, 2010
Dictionary: The number of foreign inspections where objectionable conditions were found and documented but the ORA District and/or FDA Center is not prepared to take or recommend any regulatory action at the time since the objectionable conditions may not meet the threshold for regulatory action and the firm has voluntarily corrected the conditions during the inspection or has promised immediate correction following completion of the inspection.
Fiscal Year - 2010
Measure was implemented starting January 1, 2010
| Time | Target | Number of Inspections Resulting in VAI |
|---|---|---|
| Oct 2009 | N/A | N/A |
| Nov 2009 | N/A | N/A |
| Dec 2009 | N/A | N/A |
| Jan 2010 | N/A | 6 |
| Feb 2010 | N/A | 21 |
| Mar 2010 | N/A | 15 |
| Apr 2010 | N/A | 19 |
| May 2010 | N/A | 27 |
| Jun 2010 | N/A | 30 |
| Jul 2010 | N/A | 30 |
| Aug 2010 | N/A | 29 |
| Sep 2010 | N/A | 18 |
FY 2010 Overall: 195
Percent of foreign inspections completed in the month resulting in an initial classification of Voluntary Action Indicated
Measure was implemented starting January 1, 2010
Fiscal Year - 2010
Measure was implemented starting January 1, 2010
| Time | Target | Percent of Inspections |
|---|---|---|
| Oct 2009 | N/A | N/A |
| Nov 2009 | N/A | N/A |
| Dec 2009 | N/A | N/A |
| Jan 2010 | N/A | 46 |
| Feb 2010 | N/A | 46 |
| Mar 2010 | N/A | 52 |
| Apr 2010 | N/A | 50 |
| May 2010 | N/A | 39 |
| Jun 2010 | N/A | 52 |
| Jul 2010 | N/A | 38 |
| Aug 2010 | N/A | 50 |
| Sep 2010 | N/A | 34 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
